Real-world study assesses first-line anti-PD-1, IFN-α1b, and anlotinib for advanced melanoma
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
A real-world study of patients with unresectable advanced melanoma in China has found that adding the cancer drug anlotinib to...
Tiny gold particles carrying genetic targeting molecules have produced a striking two-stage response in leukemia-like cells, briefly quieting key immune...
Exercise May Rewire the Tumor Battlefield to Empower Cancer-Killing T Cells A workout may do more than strengthen muscles and...
A new “green” nanocomposite assembled from turmeric-derived curcumin, chitosan, aloe vera and graphite nanopowder has shown a striking combination of...
For children with cancer, a device designed to make treatment easier can become a source of repeated pain, inflammation and...
Lung Cancer Screening Misses Many People Who Go on to Develop the Disease A national analysis of adults diagnosed with...
More than 2.5 million people living in the United States after a cancer diagnosis have developed at least one additional...
For surgeons operating on glioblastoma, the boundary between malignant tissue and functioning brain can be almost impossible to see under...
Cancer researchers have built a nanoscale drug-delivery system that attacks two problems inside certain tumors at once: malignant cells and...
Cancer immunotherapy is entering a more controlled and technically sophisticated phase, according to a wide-ranging collection of studies and reviews...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine